Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: A well-tolerated regimen with activity independent of p53 mutation

Martin J. Edelman, Frederick J Meyers, Tim R. Miller, Stephen G. Williams, Regina F Gandour-Edwards, Ralph W deVere White

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: A well-tolerated regimen with activity independent of p53 mutation'. Together they form a unique fingerprint.

Medicine & Life Sciences